UX016
UX016-CL210
Phase 2 small_molecule active
Quick answer
UX016 for GNE Myopathy is a Phase 2 program (small_molecule) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx UK Limited
- Indication
- GNE Myopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active